Q6Q899
Gene name |
Ddx58 |
Protein name |
Antiviral innate immune response receptor RIG-I |
Names |
DEAD box protein 58, Probable ATP-dependent RNA helicase DDX58, RIG-I-like receptor 1, RLR-1, Retinoic acid-inducible gene 1 protein, RIG-1, Retinoic acid-inducible gene I protein, RIG-I |
Species |
Mus musculus (Mouse) |
KEGG Pathway |
mmu:230073 |
EC number |
3.6.4.13: Acting on ATP; involved in cellular and subcellular movement |
Protein Class |
|
Descriptions
Autoinhibitory domains (AIDs)
Target domain |
1-186 (CARD domain) |
Relief mechanism |
Ligand binding |
Assay |
|
Accessory elements
No accessory elements
References
- Oshiumi H et al. (2013) "A distinct role of Riplet-mediated K63-Linked polyubiquitination of the RIG-I repressor domain in human antiviral innate immune responses", PLoS pathogens, 9, e1003533
- Gack MU et al. (2007) "TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity", Nature, 446, 916-920
- Ma E et al. (2008) "Autoinhibition of human dicer by its internal helicase domain", Journal of molecular biology, 380, 237-43
Autoinhibited structure
Activated structure
3 structures for Q6Q899
| Entry ID | Method | Resolution | Chain | Position | Source |
|---|---|---|---|---|---|
| 3TBK | X-ray | 214 A | A | 240-794 | PDB |
| 6BZH | X-ray | 250 A | A/B/C/D/E | 2-189 | PDB |
| AF-Q6Q899-F1 | Predicted | AlphaFoldDB |
19 variants for Q6Q899
| Variant ID(s) | Position | Change | Description | Diseaes Association | Provenance |
|---|---|---|---|---|---|
| rs215492009 | 14 | D>N | No | Ensembl | |
| rs226816483 | 113 | E>G | No | Ensembl | |
| rs259889292 | 126 | E>D | No | Ensembl | |
| rs247265874 | 133 | N>D | No | Ensembl | |
| rs27761369 | 215 | Q>R | No | Ensembl | |
| rs231647867 | 229 | P>L | No | Ensembl | |
| rs215417447 | 244 | P>A | No | Ensembl | |
| rs27761375 | 288 | C>R | No | Ensembl | |
| rs27761379 | 323 | A>S | No | Ensembl | |
| rs248026553 | 359 | G>R | No | Ensembl | |
| rs245694118 | 439 | V>E | No | Ensembl | |
| rs27761412 | 573 | H>R | No | Ensembl | |
| rs27761413 | 585 | R>Q | No | Ensembl | |
| rs223868832 | 670 | R>Q | No | Ensembl | |
| rs223697977 | 786 | V>L | No | Ensembl | |
| rs864301026 | 796 | H>Q | No | Ensembl | |
| rs227507964 | 829 | T>M | No | Ensembl | |
| rs261430342 | 834 | V>I | No | Ensembl | |
| rs264395665 | 905 | R>W | No | Ensembl |
No associated diseases with Q6Q899
Functions
| Description | ||
|---|---|---|
| EC Number | 3.6.4.13 | Acting on ATP; involved in cellular and subcellular movement |
| Subcellular Localization |
|
|
| PANTHER Family | ||
| PANTHER Subfamily | ||
| PANTHER Protein Class | ||
| PANTHER Pathway Category | No pathway information available | |
7 GO annotations of cellular component
| Name | Definition |
|---|---|
| actin cytoskeleton | The part of the cytoskeleton (the internal framework of a cell) composed of actin and associated proteins. Includes actin cytoskeleton-associated complexes. |
| bicellular tight junction | An occluding cell-cell junction that is composed of a branching network of sealing strands that completely encircles the apical end of each cell in an epithelial sheet; the outer leaflets of the two interacting plasma membranes are seen to be tightly apposed where sealing strands are present. Each sealing strand is composed of a long row of transmembrane adhesion proteins embedded in each of the two interacting plasma membranes. |
| cytoplasm | The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures. |
| cytosol | The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes. |
| plasma membrane | The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins. |
| ribonucleoprotein complex | A macromolecular complex that contains both RNA and protein molecules. |
| ruffle membrane | The portion of the plasma membrane surrounding a ruffle. |
9 GO annotations of molecular function
| Name | Definition |
|---|---|
| ATP binding | Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator. |
| ATP hydrolysis activity | Catalysis of the reaction: ATP + H2O = ADP + H+ phosphate. ATP hydrolysis is used in some reactions as an energy source, for example to catalyze a reaction or drive transport against a concentration gradient. |
| double-stranded DNA binding | Binding to double-stranded DNA. |
| double-stranded RNA binding | Binding to double-stranded RNA. |
| identical protein binding | Binding to an identical protein or proteins. |
| RNA helicase activity | Unwinding of an RNA helix, driven by ATP hydrolysis. |
| single-stranded RNA binding | Binding to single-stranded RNA. |
| ubiquitin protein ligase binding | Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins. |
| zinc ion binding | Binding to a zinc ion (Zn). |
21 GO annotations of biological process
| Name | Definition |
|---|---|
| antiviral innate immune response | A defense response against viruses mediated through an innate immune response. An innate immune response is mediated by germline encoded components that directly recognize components of potential pathogens. |
| cellular response to exogenous dsRNA | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus. |
| defense response to virus | Reactions triggered in response to the presence of a virus that act to protect the cell or organism. |
| detection of virus | The series of events in which a stimulus from a virus is received and converted into a molecular signal. |
| innate immune response | Innate immune responses are defense responses mediated by germline encoded components that directly recognize components of potential pathogens. |
| positive regulation of defense response to virus by host | Any host process that results in the promotion of antiviral immune response mechanisms, thereby limiting viral replication. |
| positive regulation of DNA-binding transcription factor activity | Any process that activates or increases the frequency, rate or extent of activity of a transcription factor, any factor involved in the initiation or regulation of transcription. |
| positive regulation of gene expression | Any process that increases the frequency, rate or extent of gene expression. Gene expression is the process in which a gene's coding sequence is converted into a mature gene product (protein or RNA). |
| positive regulation of granulocyte macrophage colony-stimulating factor production | Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production. |
| positive regulation of interferon-alpha production | Any process that activates or increases the frequency, rate, or extent of interferon-alpha production. |
| positive regulation of interferon-beta production | Any process that activates or increases the frequency, rate, or extent of interferon-beta production. |
| positive regulation of interleukin-6 production | Any process that activates or increases the frequency, rate, or extent of interleukin-6 production. |
| positive regulation of interleukin-8 production | Any process that activates or increases the frequency, rate, or extent of interleukin-8 production. |
| positive regulation of myeloid dendritic cell cytokine production | Any process that activates or increases the frequency, rate, or extent of myeloid dendritic cell cytokine production. |
| positive regulation of response to cytokine stimulus | Any process that increases the rate, frequency, or extent of a response to cytokine stimulus. |
| positive regulation of transcription by RNA polymerase II | Any process that activates or increases the frequency, rate or extent of transcription from an RNA polymerase II promoter. |
| positive regulation of tumor necrosis factor production | Any process that activates or increases the frequency, rate or extent of tumor necrosis factor production. |
| regulation of cell migration | Any process that modulates the frequency, rate or extent of cell migration. |
| response to exogenous dsRNA | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an exogenous double-stranded RNA stimulus. |
| response to virus | Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus from a virus. |
| RIG-I signaling pathway | The series of molecular signals initiated by the binding of viral RNA to a pattern recognition receptor (PRR) RIG-1 (also known as DDX58). RIG-I is a cytoplasmic receptor that detects RNA synthesized during viral replication and triggers a signaling pathway to protect the host against viral infection, for example by inducing the expression of antiviral cytokines. |
8 homologous proteins in AiPD
| UniProt AC | Gene Name | Protein Name | Species | Evidence Code |
|---|---|---|---|---|
| Q96C10 | DHX58 | ATP-dependent RNA helicase DHX58 | Homo sapiens (Human) | PR |
| Q9BYX4 | IFIH1 | Interferon-induced helicase C domain-containing protein 1 | Homo sapiens (Human) | PR |
| O95786 | RIGI | Antiviral innate immune response receptor RIG-I | Homo sapiens (Human) | EV |
| Q9UPY3 | DICER1 | Endoribonuclease Dicer | Homo sapiens (Human) | EV |
| Q8R5F7 | Ifih1 | Interferon-induced helicase C domain-containing protein 1 | Mus musculus (Mouse) | PR |
| Q9GLV6 | DDX58 | Antiviral innate immune response receptor RIG-I | Sus scrofa (Pig) | SS |
| P34529 | dcr-1 | Endoribonuclease dcr-1 | Caenorhabditis elegans | PR |
| Q6TV19 | dicer1 | Endoribonuclease Dicer | Danio rerio (Zebrafish) (Brachydanio rerio) | SS |
| 10 | 20 | 30 | 40 | 50 | 60 |
| MTAEQRQNLQ | AFRDYIKKIL | DPTYILSYMS | SWLEDEEVQY | IQAEKNNKGP | MEAASLFLQY |
| 70 | 80 | 90 | 100 | 110 | 120 |
| LLKLQSEGWF | QAFLDALYHA | GYCGLCEAIE | SWDFQKIEKL | EEHRLLLRRL | EPEFKATVDP |
| 130 | 140 | 150 | 160 | 170 | 180 |
| NDILSELSEC | LINQECEEIR | QIRDTKGRMA | GAEKMAECLI | RSDKENWPKV | LQLALEKDNS |
| 190 | 200 | 210 | 220 | 230 | 240 |
| KFSELWIVDK | GFKRAESKAD | EDDGAEASSI | QIFIQEEPEC | QNLSQNPGPP | SEASSNNLHS |
| 250 | 260 | 270 | 280 | 290 | 300 |
| PLKPRNYQLE | LALPAKKGKN | TIICAPTGCG | KTFVSLLICE | HHLKKFPCGQ | KGKVVFFANQ |
| 310 | 320 | 330 | 340 | 350 | 360 |
| IPVYEQQATV | FSRYFERLGY | NIASISGATS | DSVSVQHIIE | DNDIIILTPQ | ILVNNLNNGA |
| 370 | 380 | 390 | 400 | 410 | 420 |
| IPSLSVFTLM | IFDECHNTSK | NHPYNQIMFR | YLDHKLGESR | DPLPQVVGLT | ASVGVGDAKT |
| 430 | 440 | 450 | 460 | 470 | 480 |
| AEEAMQHICK | LCAALDASVI | ATVRDNVAEL | EQVVYKPQKI | SRKVASRTSN | TFKCIISQLM |
| 490 | 500 | 510 | 520 | 530 | 540 |
| KETEKLAKDV | SEELGKLFQI | QNREFGTQKY | EQWIVGVHKA | CSVFQMADKE | EESRVCKALF |
| 550 | 560 | 570 | 580 | 590 | 600 |
| LYTSHLRKYN | DALIISEDAQ | MTDALNYLKA | FFHDVREAAF | DETERELTRR | FEEKLEELEK |
| 610 | 620 | 630 | 640 | 650 | 660 |
| VSRDPSNENP | KLRDLYLVLQ | EEYHLKPETK | TILFVKTRAL | VDALKKWIEE | NPALSFLKPG |
| 670 | 680 | 690 | 700 | 710 | 720 |
| ILTGRGRTNR | ATGMTLPAQK | CVLEAFRASG | DNNILIATSV | ADEGIDIAEC | NLVILYEYVG |
| 730 | 740 | 750 | 760 | 770 | 780 |
| NVIKMIQTRG | RGRARDSKCF | LLTSSADVIE | KEKANMIKEK | IMNESILRLQ | TWDEMKFGKT |
| 790 | 800 | 810 | 820 | 830 | 840 |
| VHRIQVNEKL | LRDSQHKPQP | VPDKENKKLL | CGKCKNFACY | TADIRVVETS | HYTVLGDAFK |
| 850 | 860 | 870 | 880 | 890 | 900 |
| ERFVCKPHPK | PKIYDNFEKK | AKIFCAKQNC | SHDWGIFVRY | KTFEIPVIKI | ESFVVEDIVS |
| 910 | 920 | ||||
| GVQNRHSKWK | DFHFERIQFD | PAEMSV |